Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) reported the earnings of $-0.13/Share in the last quarter where the estimated EPS by analysts was $-0.13/share. The difference between the expected and actual EPS was $0/share, which represents an Earnings surprise of 0%.
Some buy side analysts are also providing their Analysis on Immune Pharmaceuticals, Inc., where 1 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. 2 Analysts reported that the Price Target for Immune Pharmaceuticals, Inc. might touch $3 high while the Average Price Target and Low price Target is $2 and $1 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. Immune Pharmaceuticals, Inc. got Initiated on 8-Oct-15 where investment firm ROTH Capital Initiated the stock to Buy.
Immune Pharmaceuticals, Inc. closed its last trading session at $0.17 with the loss of -4.14%. The Market Capitalization of the company stands at 21.9 Million. The Company has 52-week high of $0.91 and 52-week low of $0.16. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -9.89% where SMA50 and SMA200 are -25.49% and -53.61% respectively. The Company Touched its 52-Week High on Dec 3, 2015 and 52-Week Low on Nov 28, 2016.
The Relative Volume of the company is 1.18 and Average Volume (3 months) is 3.81 million. Immune Pharmaceuticals, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.33.
The company shows its Return on Assets (ROA) value of -112.1%. The Return on Equity (ROE) value stands at -508.2%. While it’s Return on Investment (ROI) value is 0%.
While looking at the Stock’s Performance, Immune Pharmaceuticals, Inc. currently shows a Weekly Performance of -4.69%, where Monthly Performance is -20.95%, Quarterly performance is -49.33%, 6 Months performance is -54.3% and yearly performance percentage is -81.67%. Year to Date performance value (YTD perf) value is -77.15%. The Stock currently has a Weekly Volatility of 12.48% and Monthly Volatility of 11.37%.